DEBORAH YORK: Open Payments
NPI 1952823403 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,489 in 32 payments from 7 companies in 2025. Trend: 2023 $22,929 · 2024 $69,047 · 2025 $10,489
Speaker / faculty: $5,940Travel & lodging: $3,134Food & beverage: $1,415
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $8,846 |
| Eli Lilly and Company | 3 | $578 |
| Biogen, Inc. | 3 | $288 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $284 |
| ABBVIE INC. | 6 | $250 |
| Alkermes, Inc. | 2 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $96 |
Products named: FANAPT, CAPLYTA, VRAYLAR, ZURZUVAE, ARISTADA.
Industry payments across CO — which companies pay providers there.
